Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)

Frequently Asked Questions About Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)

How can consumers provide feedback to Haleon?

Consumers can provide feedback to Haleon through various channels, including the company's official website and social media platforms. Haleon values consumer input and encourages customers to share their experiences with its products. This feedback is essential for continuous improvement and helps the company understand consumer preferences and expectations.

How does Haleon approach research and development?

Haleon invests significantly in research and development (R&D) to create innovative consumer health products that meet evolving consumer needs. The company collaborates with healthcare professionals and leverages consumer insights to identify new opportunities and improve existing products. This ongoing commitment to R&D helps Haleon maintain its competitive edge and enhance its product offerings.

How does Haleon ensure product quality and safety?

Haleon ensures product quality and safety through rigorous quality control processes and adherence to regulatory standards in the consumer health industry. The company conducts extensive testing and monitors its products throughout the supply chain, ensuring they meet safety and efficacy standards. Haleon is committed to transparency and communicates its quality assurance practices to consumers.

How does Haleon prioritize sustainability?

Haleon prioritizes sustainability by integrating environmentally responsible practices throughout its operations. The company aims to reduce its environmental impact through sustainable sourcing, minimizing waste, and improving the recyclability of its packaging. Haleon also emphasizes transparency and aims to collaborate with stakeholders to support health and sustainability initiatives in communities.

In what regions does Haleon operate?

Haleon operates globally, with a presence in various regions including North America, Europe, Asia-Pacific, and Latin America. The company's extensive distribution network allows it to cater to diverse consumer needs across different markets, leveraging local insights to drive brand engagement and improve accessibility to health solutions worldwide.

What are American Depositary Shares (ADS) and how do they relate to Haleon?

American Depositary Shares (ADS) are a way for U.S. investors to buy shares in foreign companies, and in the case of Haleon plc, each ADS represents two ordinary shares of the company. By trading on the NYSE under the ticker HLN, Haleon allows investors in the U.S. to easily buy and sell shares while providing liquidity and access to its consumer health portfolio.

What are some popular brands owned by Haleon?

Haleon owns several well-recognized consumer health brands, including Sensodyne and Panadol for pain relief, Voltaren for muscle and joint pain, and Centrum vitamins. Other notable brands in Haleon's portfolio are Theraflu for respiratory health and Aquafresh for oral care. This diverse range of products caters to various health and wellness needs across all age groups.

What can investors expect from Haleon plc in the future?

Investors can expect Haleon plc to focus on innovation, strategic partnerships, and expansion into emerging markets in the future. The company is likely to continue investing in research and development to launch new products that meet consumer needs while enhancing its existing portfolio. Additionally, maintaining a disciplined approach to financial management will be key as Haleon aims for sustainable growth.

What challenges does Haleon face in the consumer health market?

Haleon faces several challenges in the consumer health market, including intense competition, changing consumer preferences, and regulatory pressures. The company must remain agile and responsive to market dynamics while navigating the complexities of a global supply chain. Additionally, maintaining consumer trust and meeting evolving health trends are critical factors as Haleon seeks to strengthen its brand presence.

What does Haleon plc do?

Haleon plc is a global consumer health company that focuses on delivering everyday health products. Formed as a spin-off from GlaxoSmithKline in 2022, Haleon's portfolio includes well-known brands in categories such as oral health, pain relief, respiratory health, and vitamins and supplements. The company is dedicated to enhancing consumer well-being by providing accessible health solutions.

What financial performance has Haleon plc shown since its spin-off?

Since its spin-off in 2022, Haleon plc has demonstrated steady financial performance, with a focus on revenue growth driven by strong brand recognition and demand for its products. The company has reported an increase in sales across its key categories, indicating a positive response from consumers. Investors continue to closely monitor Haleon's financial results as it builds its presence in the consumer health market.

What impact does Haleon aim to have on consumer health?

Haleon aims to have a positive impact on consumer health by offering accessible products that promote day-to-day wellness and preventative care. By focusing on efficacy and safety, the company aims to enhance the quality of life for individuals and families, fostering healthier communities. Haleon's commitment to consumer health drives its dedication to innovation and product development.

What initiatives has Haleon undertaken to promote health education?

Haleon is committed to promoting health education through various initiatives designed to empower consumers with knowledge about health and wellness. These initiatives may include community outreach programs, partnerships with healthcare professionals, and online resources that provide credible information on topics such as nutrition, oral health, and managing common ailments.

What is Haleon’s mission or vision statement?

Haleon’s mission is to deliver products that help people take care of their health and well-being in their everyday lives. The company is dedicated to enhancing the lives of consumers by combining science and consumer insights to provide trusted health products. This vision reflects Haleon’s commitment to empowering individuals to live healthier lives and achieve optimal well-being.

What is the governance structure of Haleon plc?

Haleon plc has a governance structure that is designed to ensure transparency and accountability. The board of directors comprises a diverse group of individuals with extensive experience in various sectors, providing strategic guidance and oversight. The governance framework includes various committees to address key areas such as audit, risk, and remuneration, aligning with best practices in corporate governance.

What recent news has occurred regarding Haleon plc?

As of October 2023, Haleon plc has been focused on expanding its product offerings and strengthening its market position through strategic partnerships and innovations. The company has also emphasized growth in emerging markets and continues to adapt to changing consumer preferences. Recent product launches and innovations have drawn attention in the health and wellness sector as Haleon seeks to diversify its portfolio.

When was Haleon plc founded?

Haleon plc was officially founded on July 18, 2022, following its spin-off from GlaxoSmithKline (GSK). This marked the beginning of Haleon as a standalone entity focused exclusively on consumer health, separate from GSK's pharmaceutical and vaccine divisions. Since its inception, Haleon has focused on delivering over-the-counter health products to consumers worldwide.

Where is Haleon plc headquartered?

Haleon plc is headquartered in Weybridge, Surrey, United Kingdom. It operates with a global presence, serving consumers in multiple markets around the world while maintaining its corporate headquarters in the UK. The strategic location allows Haleon to leverage its heritage in the consumer health space while expanding its footprint internationally.

Who are Haleon plc's primary competitors?

Haleon plc competes with several major companies in the consumer health sector, including Johnson & Johnson, Procter & Gamble, and Reckitt Benckiser. These companies also offer a wide range of over-the-counter healthcare products and personal care items, creating a competitive landscape in which innovation, brand recognition, and consumer trust are vital for success.

What is the current price of Haleon plc American Depositary Shares (Each representing two Ordinary Shares)?

The current price of Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is 10.16

When was Haleon plc American Depositary Shares (Each representing two Ordinary Shares) last traded?

The last trade of Haleon plc American Depositary Shares (Each representing two Ordinary Shares) was at 7:00 pm EDT on April 2nd, 2025